<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Site da Brakke Consulting</provider_name><provider_url>https://brakkeconsulting.com/pt</provider_url><title>News from Brakke Consulting</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="ZyVy4LJvTa"&gt;&lt;a href="https://brakkeconsulting.com/pt/20095/"&gt;Not&#xED;cias e notas sobre sa&#xFA;de animal de 10 de janeiro de 2003&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://brakkeconsulting.com/pt/20095/embed/#?secret=ZyVy4LJvTa" width="600" height="338" title="&#x201C;Animal Health News &amp; Notes for January 10, 2003&#x201D; &#x2014; Brakke Consulting Website" data-secret="ZyVy4LJvTa" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://brakkeconsulting.com/wp-includes/js/wp-embed.min.js
/* ]]&gt; */
&lt;/script&gt;</html><description>****************************************************************** Brakke Consulting&rsquo;s Animal Health News &amp; Notes for January 10, 2003 Copyright &copy; Brakke Consulting, Inc. ****************************************************************** COMPANY NEWS RELEASES &gt;&nbsp; KMG Chemicals, Inc. announced its acquisition of the Rabon insecticidal product lines of Boehringer Ingelheim Vetmedica, Inc., effective as of December 30, 2002.&nbsp; As part of the transaction, KMG has also acquired the product registration for Ravap Insecticide Spray.&nbsp; Both KMG and Boehringer Ingelheim Vetmedica will produce and market this spray composed of Rabon and other ingredients.&nbsp; Boehringer Ingelheim Vetmedica will continue to market the product under its Ravap trademark.&nbsp; Other assets acquired in the transaction include equipment, certain inventory, product registrations for other Rabon products, and other intangible assets. Financial terms were not disclosed.&nbsp; (company press release) &gt;&nbsp; Synbiotics Corporation announced that Paul Hays has joined the Company as President and Chief Operating Officer. Mr. Hays was also appointed to the Synbiotics Corporation Board of Directors. Mr. Hays brings eighteen years of experience in the animal health market. He was previously employed at Boehringer Ingelheim Vetmedica, Inc. for approximately ten years where he served in various senior management positions.&nbsp; Mr. Hays has also served on the Boards of the Animal Health Institute and the American Feed Industry Association. (Yahoo News) &gt;&nbsp; Intervet has signed a research agreement with Oxford BioMedica to develop TroVAX-VET, an anti-cancer gene therapyView Full Post;</description></oembed>
